Sutter Health Research Enterprise
795 El Camino Real
Palo Alto, CA, 94301
(650) 853-2983
kaneshr@pamf.org
Primary Research Interests
Related Clinical Trials
A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with PPMS
Investigators: Minal Bhanushali MD, PAMFRI Medical Director, David Gershfield MD, Ariele L Greenfield M.D., Director of PAMF Multiple Sclerosis Center, Neurologist and Researcher, Christine Hessler MD
Status: Active, Not Recruiting